LCZ696 (CAS 936623-90-4) is a fixed-dose angiotensin receptor-neprilysin inhibitor complex composed of sacubitril and valsartan. It is a white to off-white powder used as the active pharmaceutical ingredient in heart-failure therapy, combining neprilysin inhibition with AT1 receptor blockade.
LCZ696
Category:Organic Intermediates
CAS No.:936623-90-4
Product Grade: Pharma grade
Purity / Assay: 98%
Molecular Formula:Variable composition
Molecular Weight:Variable
EINECS No.:Empty
Synonym(s):Sacubitril valsartan sodium; Entresto API; LCZ696
LCZ696 (CAS 936623-90-4) is a fixed-dose angiotensin receptor-neprilysin inhibitor complex composed of sacubitril and valsartan. It is a white to off-white powder used as the active pharmaceutical ingredient in heart-failure therapy, combining neprilysin inhibition with AT1 receptor blockade.
1. Used as the API for heart failure with reduced ejection fraction and related cardiovascular indications. 2. Serves as a combined neprilysin inhibitor and angiotensin II receptor blocker in a single fixed-dose complex. 3. Applied in cardiovascular pharmaceutical research and clinical formulation development. 4. Functions as a reference standard for LCZ696 assay, impurity profiling and bioequivalence studies.
25kg/drum; 200kg/drum
CAS No.: 936623-90-4
Product Name: LCZ696
Purity / Assay:98%
Molecular Formula:Variable composition
Molecular Weight:Variable
EINECS No.:Empty
Synonym(s):Sacubitril valsartan sodium; Entresto API; LCZ696
For global customers, we provide complete technical documentation to support product evaluation, regulatory compliance and safe handling during transportation and application.